Author:
Roth Thomas,Coulouvrat Catherine,Hajak Goeran,Lakoma Matthew D.,Sampson Nancy A.,Shahly Victoria,Shillington Alicia C.,Stephenson Judith J.,Walsh James K.,Kessler Ronald C.
Funder
Sanofi-Aventis
Aventis
Cephalon
GlaxoSmithKline
Merck
Neurocrine
Pfizer
Sanofi
SchoeringPlough
Sepracor
Somaxon
Syrex
Takeda
Transoral
Wyeth
XenoPort
Actelion
Affectis
AstraZeneca
BrainLab
Daimler Benz
Essex
Lundbeck
Neurim
NeuroBiotec
Novartis
Organon
Schwarz
UCB
Volkswagen
Weinmann
Shire Development, Inc.
Janssen Pharmceutica
Daiichi Sankyo
Biogen
Abbott Laboratories
Shire
Affymax
Adolor
Merck & Co.
Evotec
Vanda
Neurogen
Ventus
Respironics
Jazz Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly and Company
Johnson and Johnson Pharmaceuticals
Ortho-McNeil Pharmaceuticals, Inc.
Pfizer, Inc.
Reference73 articles.
1. Incidence and risk factors of insomnia in a population-based sample;LeBlanc;Sleep,2009
2. Epidemiology of insomnia: A longitudinal study in a UK population;Morphy;Sleep,2007
3. Impairment associated with sleep problems in the community: Relationship to physical and mental health comorbidity;Stein;Psychosom Med,2008
4. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR),2000
5. International Classification of Diseases (ICD-10),1991
Cited by
371 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献